Advertisement

ADVERTISEMENT

Robert Fee

Conference Coverage
Case Study Assesses Self-Reported Financial Difficulties Among Patients With Multiple Myeloma or Chronic Lymphocytic Leukemia
06/09/2022
A study presented by the Alliance for Clinical Trials in Oncology at the 2022 ASCO Annual Meeting confirms that many patients with blood cancers experience financial difficulties.
A study presented by the Alliance for Clinical Trials in Oncology at the 2022 ASCO Annual Meeting confirms that many patients with blood cancers experience financial difficulties.
A study presented by the...
06/09/2022
Journal of Clinical Pathways
Conference Coverage
Study Examines Charges Associated With US Hospital Payer-Specific Negotiated Mammography
06/09/2022
A cross-sectional study of US acute care and critical access hospitals presented at the 2022 ASCO Annual Meeting examined the factors associated with payer-negotiated mammography charges.
A cross-sectional study of US acute care and critical access hospitals presented at the 2022 ASCO Annual Meeting examined the factors associated with payer-negotiated mammography charges.
A cross-sectional study of US...
06/09/2022
Journal of Clinical Pathways
News
ASCO Establishes Center for Equity, Diversity, and Inclusion
04/22/2022
The American Society of Clinical Oncology (ASCO) recently created the ASCO Center for Equity, Diversity, and Inclusion, which is designed to promote equity, diversity, and inclusion (EDI) goals across the organization and throughout the wider...
The American Society of Clinical Oncology (ASCO) recently created the ASCO Center for Equity, Diversity, and Inclusion, which is designed to promote equity, diversity, and inclusion (EDI) goals across the organization and throughout the wider...
The American Society of Clinical...
04/22/2022
Journal of Clinical Pathways
Conference Coverage
Bringing the Benefits of At-home Programs to Patients With Cancer Who Live in Rural Areas
06/09/2022
Researchers show how patients with cancer who are living in rural communities can receive the benefits of oncology hospital at home programs in a case study from the 2022 ASCO Annual Meeting.
Researchers show how patients with cancer who are living in rural communities can receive the benefits of oncology hospital at home programs in a case study from the 2022 ASCO Annual Meeting.
Researchers show how patients...
06/09/2022
Journal of Clinical Pathways
Conference Coverage
Bendamustine Plus Rituximab Among Older Patients With Newly Diagnosed Mantle Cell Lymphoma
06/04/2022
Research presented at ASCO demonstrates that ibrutinib, when combined with bendamustine-rituximab, improved progression-free survival by 50% for older patients with newly diagnosed mantle cell lymphoma.
Research presented at ASCO demonstrates that ibrutinib, when combined with bendamustine-rituximab, improved progression-free survival by 50% for older patients with newly diagnosed mantle cell lymphoma.
Research presented at ASCO...
06/04/2022
Journal of Clinical Pathways
Conference Coverage
Pharmacist Interventions in Oral Oncolytics Program Shown to Provide Cost Savings
06/04/2022
A study presented at the 2022 ASCO Annual Meeting shows that pharmacist interventions in the Pharmacist-Managed Oral Chemotherapy Clinic at Kaiser Permanente San Diego led to significant overall cost savings to the health care system.
A study presented at the 2022 ASCO Annual Meeting shows that pharmacist interventions in the Pharmacist-Managed Oral Chemotherapy Clinic at Kaiser Permanente San Diego led to significant overall cost savings to the health care system.
A study presented at the 2022...
06/04/2022
Journal of Clinical Pathways
Conference Coverage
Bevacizumab-awwb Safe, Effective Among Patients With Metastatic Colorectal Cancer
06/04/2022
Study examines real-world effectiveness and safety of Bevacizumab-awwb, the first FDA-approved biosimilar to Avastin, among patients with metastatic colorectal cancer.
Study examines real-world effectiveness and safety of Bevacizumab-awwb, the first FDA-approved biosimilar to Avastin, among patients with metastatic colorectal cancer.
Study examines real-world...
06/04/2022
Journal of Clinical Pathways
Conference Coverage
The Financial Impact of Biosimilar Adoption in the Oncology Care Model
06/05/2022
In a study presented at the 2022 ASCO Annual Meeting, researchers examined the utilization and the financial impact of biosimilar adoption in The US Oncology Network Over a six-month period.
In a study presented at the 2022 ASCO Annual Meeting, researchers examined the utilization and the financial impact of biosimilar adoption in The US Oncology Network Over a six-month period.
In a study presented at the 2022...
06/05/2022
Journal of Clinical Pathways
Conference Coverage
Real-world Treatment Patterns for Patients With Metastatic Castration-Resistant Prostate Cancer
06/06/2022
Although numerous treatments with different mechanisms of action are approved for metastatic castration-resistant prostate cancer (mCRPC), the sequencing for management of these patients has been evolving post availability of trials.
Although numerous treatments with different mechanisms of action are approved for metastatic castration-resistant prostate cancer (mCRPC), the sequencing for management of these patients has been evolving post availability of trials.
Although numerous treatments...
06/06/2022
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

November 6 ⁠–⁠ November 8
NEI Congress
November 7 ⁠–⁠ November 10
ECS
November 8 ⁠–⁠ November 10
WoundCon
November 8
Dermatology Week
November 13 ⁠–⁠ November 16
Psych Congress Primary Care Online Series
November 14 ⁠–⁠ November 15
November 23 ⁠–⁠ November 24
December 4 ⁠–⁠ December 5
Great Debates & Updates in Diabetic Foot
December 6 ⁠–⁠ December 7
AIBD logo
December 9 ⁠–⁠ December 11
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use